Close Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

High-Tech Gründerfonds

Investor type Venture Capital
Founders Alexander von Frankenberg


Unlock datapoints

Portfolio analytics



News & Media

Add fund to favorites
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Looking for a perfect list of funds?

Get recommendations from our smart algorithm

Get the list
Total investments 785
Average round size
The average size of a deal this fund participated in
Portfolio companies 568
Rounds per year 43.61
Lead investments 140
Follow on index
How often the fund supports its portfolio startups at next rounds
Exits 78
Key employees 8
Stages of investment
Early Stage Venture

Areas of investment

  • Software
  • Biotechnology
  • Health Care
  • Information Technology
  • SaaS

The overall number of key employees were 16.

The typical startup value when the investment from High-Tech Gru00fcnderfonds is 5-10 millions dollars. The increased amount of exits for fund were in 2019. The important activity for fund was in 2013. The fund is constantly included in 25-48 investment rounds annually. The common things for fund are deals in the range of 1 - 5 millions dollars.

The fund has no exact preference in a number of founders of portfolio startups. In case when startup counts 4 of the founder, the chance for it to get the investment is meager. Moreover, a startup needs to be at the age of 2-3 years to get the investment from the fund. We can highlight the next thriving fund investment areas, such as Mobile, Health Care. Among the various public portfolio startups of the fund, we may underline Outfittery, Mister Spex, GWA Hygiene

The typical case for the fund is to invest in rounds with 2-3 participants. Despite the High-Tech Gru00fcnderfonds, startups are often financed by KfW, Peppermint Venture Partners, Earlybird Venture Capital. The meaningful sponsors for the fund in investment in the same round are Neuhaus Partners, NRW.BANK, MBG Baden Wuerttemberg. In the next rounds fund is usually obtained by Wellington Partners, Creathor Ventures, bm-t beteiligungsmanagement thu00fcringen.

Read more

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation


$1M16 Jan 2023 Zug, Zug, Switzerland

Refuel Green

Environmental Consulting
Renewable Energy
$1M12 Jan 2023 Dresden, Sachsen, Germany


Health Care
11 Jan 2023 -


Artificial Intelligence
Machine Learning
$2M10 Jan 2023 Osnabrück, Lower Saxony, Germany


Cyber Security
Information Technology
Network Security
$37M19 Dec 2022 Bochum, North Rhine-Westphalia, Germany


Renewable Energy
15 Dec 2022 Münster, Nordrhein-Westfalen, Germany


07 Dec 2022 Stuttgart, Baden-Wurttemberg, Germany

Reflex Aerospace

Satellite Communication
Space Travel
$8M05 Dec 2022 Berlin, Berlin, Germany

Crocus Labs

Smart Home
23 Nov 2022 Berlin, Berlin, Germany
Cardior Raises €64M in Series B Funding

– Cardior Pharmaceuticals from Hanover develops non-coding RNA (ncRNA)-based therapeutics for patients with cardiac diseases.
– The company closed a €64m ($76m) Series B financing round.
– The round was led by Inkef Capital, supported by fellow new investors Fund+, Sunstone, Hadean Ventures and Coparion with participation from existing investors including LSP, BioMedPartners, Bristol Myers Squibb and High-Tech Gründerfonds.
– The new investment will be used for the late-stage clinical development of its lead program and the expansion of its earlier-stage pipeline.

Alentis Therapeutics Raises $67M in Series B Financing

– Alentis Therapeutics from Basel develops new treatments for fibrotic diseases.
– The company raised $67m in Series B financing round.
– The round was led by Morningside Venture Investments, joined by Jeito Capital and Series A investors BioMed Partners, BB Pureos Bioventures, Bpifrance through its InnoBio 2 fund, High-Tech Gründerfonds and Schroders Capital.
– The new investment will be used to support the company’s drug discovery programs targeting other fibrotic diseases and hepatobiliary cancers.


  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent High-Tech Gründerfonds?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!

You can raise money with us faster

Get matched with relevant funds

Find decision makers data

Connect with investors by email

Remind me later
...and save more than 200 hours*
*-Our recommendation and outreach system saves up to 200 hours of founder time on fundraising for seed and series A+ startups
We use LinkedIn only to verify your account. We don't import or message your contacts, nor post on your behalf.
By creating an account, you agree to our Terms of Service and Privacy Policy.
Crunchbase icon

Content report

The following text will be sent to our editors: